Gene Bridges GmbH

Gene Bridges GmbH, founded 2000 as a spin-off of the European Molecular Biology Laboratories (EMBL), commercialises the patented Red/ET Recombineering technology.

Gene Bridges GmbH Headquarters and R&D are in the Bio-Innovation Centre (BIOZ) in Dresden, Germany. BIOZ is part of Biopolis Dresden, a broad-based, pure and applied, initiative to create excellence in research and biotechnology. In May 2004, Gene Bridges opened its Commercial Centre (Licensing, DNA Engineering Services, Kit development) in the Technology Park in Heidelberg. The company was founded by Dr. A. Francis Stewart, who was a Group Leader at European Molecular Biology Laboratory (EMBL) Heidelberg, where his group specialized in advanced genetic engineering strategies using site specific and homologous recombination.

Red/ET is a revolutionary method for DNA engineering

Recombineering with Red/ET allows unlimited cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome.

To know more about the technology and the kits available, please go to www.genebridges.com.